Huaidong Hu
- Molecular Medicine top 5%
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
- Cancer, Hypoxia, and Metabolism 4
-
- Drug Transport and Resistance Mechanisms 5
- Hepatology top 10%
-
- Immunotherapy and Immune Responses 3
-
- Advanced Proteomics Techniques and Applications 3
-
- Endoplasmic Reticulum Stress and Disease 3
-
- Ferroptosis and cancer prognosis 3
-
- Peroxisome Proliferator-Activated Receptors 3
- Journals
- Journal of Cellular Biochemistry (5 papers)International Journal of Oncology (4 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Huaidong Hu
28 papers receiving 848 citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 110
- Cancer Research 201
- Oncology 183
- Hepatology 53
- Immunology 136
Countries citing papers authored by Huaidong Hu
This map shows the geographic impact of Huaidong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaidong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaidong Hu more than expected).
Fields of papers citing papers by Huaidong Hu
This network shows the impact of papers produced by Huaidong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaidong Hu. The network helps show where Huaidong Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huaidong Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2020 | 11 | |
| 3 | 2018 | 9 | |
| 4 | 2017 | 30 | |
| 5 | 2017 | 177 | |
| 6 | 2015 | 10 | |
| 7 | 2014 | 35 | |
| 8 | 2014 | 36 | |
| 9 | 2012 | 27 | |
| 10 | 2012 | 91 | |
| 11 | 2011 | 42 | |
| 12 | 2011 | 36 | |
| 13 | 2010 | 44 | |
| 14 | 2010 | 25 | |
| 15 | 2009 | 43 | |
| 16 | 2009 | 0 | |
| 17 | 2008 | 25 | |
| 18 | 2007 | 77 | |
| 19 | 2007 | 14 | |
| 20 | 2007 | 17 |
About Huaidong Hu
Huaidong Hu is a scholar working on Cancer Research, Oncology and Molecular Medicine, having authored 29 papers that have together received 864 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Ferroptosis and cancer prognosis (3 papers), Immunotherapy and Immune Responses (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Molecular Medicine (110 citations), Cancer Research (201 citations) and Oncology (183 citations). Huaidong Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hong Ren, Yixuan Yang, Peng Hu, Jiaojiao Gong, Shasha Shen, Si Qin, Juan Huang, Sanglin Li, Rong Xiang and Dazhi Zhang. Their work appears in journals such as Journal of Cellular Biochemistry, International Journal of Oncology, Cellular Physiology and Biochemistry, Scientific Reports and Virology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.